Oncologists and researchers use a measurement known as Response Evaluation Criteria in Solid Tumors (RECIST) to evaluate the degree to which a patient's cancer responds to treatment during clinical trials. The tool is key ...
Nov 6, 2017
0
1
For many years, oncologists have known that cancers can secrete complex molecules into the blood and that levels of these molecules can be easily measured. These so-called 'tumor markers' are traditionally associated with ...
Sep 6, 2017
0
1
Despite a decade-long call for simplification of clinical trials, the number of criteria excluding patients from participating in clinical trials for lung cancer research continues to rise.
Aug 14, 2017
0
1
Eligibility criteria continue to increase in number and complexity for lung cancer clinical trials.
Aug 10, 2017
0
1
Lung cancer screening is likely to be cost-effective, particularly if it also identifies other tobacco-related conditions in high-risk people, suggests new research published in the Journal of Thoracic Oncology (JTO).
Jun 29, 2017
0
2
Capturing and summarizing the remarkable progress in lung cancer prevention, diagnosis, staging and treatment in 2016, the International Association for the Study of Lung Cancer (IASLC) announces the second annual publication ...
Jun 8, 2017
0
0
Elderly patients with early-stage esophageal cancer that received treatment had an increased 5-year overall survival when compared to patients who received observation with no treatment.
Apr 27, 2017
0
1
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Feb 16, 2017
0
0
Elderly non-small cell lung cancer (NSCLC) patients undergoing definitive radiation have a lower incidence of esophagitis compared to younger patients and tolerate aggressive standard treatment regimens.
Feb 1, 2017
0
0
Non-small cell lung cancer (NSCLC) patients with advanced disease receiving standard of care treatment have a higher overall survival (OS) than similar patients not receiving treatment.
Jan 18, 2017
0
0
